Holger Lode
Overview
Explore the profile of Holger Lode including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
190
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vollmer M, Kuthning D, Gramenz J, Scholz A, Michael R, Wittmann N, et al.
PeerJ
. 2024 Nov;
12:e18384.
PMID: 39544417
Background: Limited data on SARS-CoV-2 seroprevalence in rural areas of northern Germany necessitate comprehensive cohort studies. We aimed to evaluate the seroprevalence, silent infection (SI) rates and risk factors for...
2.
Corbacioglu S, Lode H, Ellinger S, Zeman F, Suttorp M, Escherich G, et al.
Lancet Oncol
. 2024 Jun;
25(7):922-932.
PMID: 38936379
Background: Neuroblastoma is the most common extracranial solid tumour in children. Relapsed or refractory neuroblastoma is associated with a poor outcome. We assessed the combination of irinotecan-temozolomide and dasatinib-rapamycin (RIST)...
3.
Fischer-Riepe L, Kailayangiri S, Zimmermann K, Pfeifer R, Aigner M, Altvater B, et al.
Clin Cancer Res
. 2024 Apr;
30(16):3564-3577.
PMID: 38593230
Purpose: Cytokine-engineering of chimeric antigen receptor-redirected T cells (CAR T cells) is a promising principle to overcome the limited activity of canonical CAR T cells against solid cancers. Experimental Design:...
4.
El Refaee E, Fleck S, Matthes M, Lode H, Vogelgesang S, Schroeder H
Childs Nerv Syst
. 2023 Jul;
39(12):3435-3443.
PMID: 37401973
Background: Reaching a tumor within the third ventricle is challenging, and planning an accessible trajectory is crucial without injuring the surrounding structures. We report a 5-year-old boy presented with headache...
5.
Abele N, Langner S, Felbor U, Lode H, Hosten N
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046600
Neuroblastoma is the most common extracranial, malignant, solid tumor found in children. In more than one-third of cases, the tumor is in an advanced stage, with limited resectability. The treatment...
6.
Wieczorek A, Zaniewska-Tekieli A, Ehlert K, Pawinska-Wasikowska K, Balwierz W, Lode H
Front Oncol
. 2023 Feb;
13:1082771.
PMID: 36816982
Prognosis in children with refractory and relapsed high-risk neuroblastoma is poor. Only a minority of patients obtain remission when treated with second-line chemotherapy regimens. Chemotherapy combined with anti-GD2 antibodies has...
7.
Forkel H, Grabarczyk P, Depke M, Troschke-Meurer S, Simm S, Hammer E, et al.
Oncoimmunology
. 2022 Dec;
11(1):2148850.
PMID: 36507091
BCL11B, an essential transcription factor for thymopoiesis, regulates also vital processes in post-thymic lymphocytes. Increased expression of BCL11B was recently correlated with the maturation of NK cells, whereas reduced BCL11B...
8.
Marx S, Wilken F, Miebach L, Ispirjan M, Kinnen F, Paul S, et al.
Cancers (Basel)
. 2022 Dec;
14(23).
PMID: 36497232
Glioblastoma is the most common and lethal primary brain malignancy that almost inevitably recurs as therapy-refractory cancer. While the success of immune checkpoint blockade (ICB) revealed the immense potential of...
9.
Zwicker P, Schmidt T, Hornschuh M, Lode H, Kramer A, Muller G
Biomater Res
. 2022 Jan;
26(1):1.
PMID: 35000621
Aim: Periprosthetic joint infections are a devastating complication after arthroplasty, leading to rejection of the prosthesis. The prevention of septic loosening may be possible by an antimicrobial coating of the...
10.
Ehlert K, Hansjuergens I, Zinke A, Otto S, Siebert N, Henze G, et al.
J Immunother Cancer
. 2020 May;
8(1).
PMID: 32414861
Background: Neuroblastoma (NB) is the most frequent extracranial solid tumor in children. More than 50% of patients present with widespread (stage M) or refractory disease. In these patients, event-free and...